End‐stage renal disease as an independent risk factor for in‐hospital mortality after coronary drug‐eluting stenting: Understanding and modeling the risk

We sought to compare in‐hospital outcomes between patients with and without end‐stage renal disease (ESRD) undergoing coronary drug‐eluting stent (DES) placement and to model risk of in‐hospital adverse postpercutaneous coronary intervention (PCI) events in ESRD patients.

[1]  Francesca N. Delling,et al.  Heart Disease and Stroke Statistics—2019 Update: A Report From the American Heart Association , 2019, Circulation.

[2]  Raman S. Dusaj,et al.  Percutaneous Coronary Intervention and Inpatient Mortality in Patients with Advanced Chronic Kidney Disease Presenting with Acute Coronary Syndrome , 2017, Proceedings.

[3]  D. Antoniucci,et al.  Second vs. First generation drug eluting stents in multiple vessel disease and left main stenosis: Two‐year follow‐up of the observational, prospective, controlled, and multicenter ERACI IV registry , 2017, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[4]  T. Deb.  Periprocedural Myocardial Infarction , 2016, Indian Journal of Cardiovascular Disease in Women WINCARS.

[5]  J. Messenger,et al.  The Impact of Bleeding Avoidance Strategies on Hospital-Level Variation in Bleeding Rates Following Percutaneous Coronary Intervention: Insights From the National Cardiovascular Data Registry CathPCI Registry. , 2016, JACC. Cardiovascular interventions.

[6]  C. Reid,et al.  Incidence, Predictors and Outcomes of Major Bleeding in Patients Following Percutaneous Coronary Interventions in Australia. , 2016, Heart, lung & circulation.

[7]  Mandeep Singh,et al.  An updated bleeding model to predict the risk of post-procedure bleeding among patients undergoing percutaneous coronary intervention: a report using an expanded bleeding definition from the National Cardiovascular Data Registry CathPCI Registry. , 2013, JACC. Cardiovascular interventions.

[8]  A. Jeremias,et al.  CORONARY ARTERY DISEASE Original Studies Impact of Severity of Renal Dysfunction on Determinants of In-Hospital Mortality Among Patients Undergoing Percutaneous Coronary Intervention , 2012 .

[9]  M. Hadamitzky,et al.  Validation of the Bleeding Academic Research Consortium Definition of Bleeding in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention , 2012, Circulation.

[10]  A. Jeremias,et al.  Effect of gender and race on outcomes in dialysis-dependent patients undergoing percutaneous coronary intervention. , 2011, The American journal of cardiology.

[11]  E. Tuzcu,et al.  Enhanced prediction of mortality after percutaneous coronary intervention by consideration of general and neurological indicators. , 2011, JACC. Cardiovascular interventions.

[12]  G. Stone,et al.  Periprocedural Myocardial Infarction: Prevalence, Prognosis, and Prevention , 2010, Circulation. Cardiovascular interventions.

[13]  S. Pocock,et al.  A risk score to predict bleeding in patients with acute coronary syndromes. , 2010, Journal of the American College of Cardiology.

[14]  Samin K. Sharma,et al.  A risk score to predict in-hospital mortality for percutaneous coronary interventions. , 2006, Journal of the American College of Cardiology.

[15]  A. Defranco,et al.  Prognostic Implication of Anemia on In-Hospital Outcomes After Percutaneous Coronary Intervention , 2004, Circulation.

[16]  H. Miyata,et al.  Incidence and predictors of bleeding complications after percutaneous coronary intervention. , 2017, Journal of cardiology.

[17]  S. Matoba,et al.  Prognostic impact of chronic kidney disease and anemia at admission on in-hospital outcomes after primary percutaneous coronary intervention for acute myocardial infarction. , 2014, International heart journal.